Lawsuit Claims Abbott Sales Reps Practiced Medicine Without a License While Adjusting Spinal Cord Stimulator
Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Gabapentin Dementia Lawsuit Gabapentin dementia lawsuits are being investigated against Pfizer and other drug manufacturers following studies linking the widely prescribed medication to an increased risk of dementia, Alzheimer's disease and mild cognitive impairment. Learn about the allegations, recent research, lawsuit updates and potential settlement compensation.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
EPA Unveils Strategy For Commercial Chemical Evaluations January 18, 2017 Russell Maas Add Your CommentsFederal environmental safety officials have announced three new rules that are designed to form the backbone of a strategy that will evaluate and regulate new chemicals, to help determine potential risks to the public health and environment.ย The Environmental Protection Agency (EPA) announced the proposed rules on January 13, which would establish the first-ever, comprehensive regulatory strategy for chemicals entering U.S. commerce.The three new rules follow the passing of The Frank R. Lautenberg Chemical Safety for the 21st Century Act, which was signed into law by President Barack Obama on June 22, 2016, as the first update to the Toxic Substances Control Act (TSCA) since it was originally enacted in 1976.Do You Know about…Spinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONDo You Know AboutโฆSpinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONIn addition to the new “foundational” rules, the EPA has also proposed three rules restricting specific high risk uses of a number of chemicals. The rules must be finalized by June 2017, according to mandates set in the new chemical law.Oversight and regulation has become a necessity for chemicals entering U.S. commerce, given the new technology and scientific developments that prove certain popular household chemicals used heavily over the last forty years may actually be harmful and cause diseases from overexposure, experts say.The EPA indicates that the proposed rules will set into motion a process designed to quickly evaluate chemicals that have been entered into commerce over the last decade, by granting them the authority to identify chemicals made in, imported into or processed within the U.S. The EPA will decide which of those have potential health and environmental risks through the use of scientific data and assess those risks and pursue regulatory controls as needed.As part of the new rules, the EPA will be required to systemically prioritize existing chemical substances that have entered the market within the past 10 years. The new process will be managed by the EPAโs Office of Chemical Safety and Pollution Prevention and Office of General Counsel.The American Chemistry Council released a statement praising the EPA for their fast development and implementation of the new chemical evaluation rules. Since Congress last amended the TSCA when it was enacted into law in 1976, tens of thousands of chemicals were automatically grandfathered into production as presumable safe materials without any federal or scientific evaluation to assess their risk to human or environmental risks.According to prior research by the EPA, of the 85,000 known chemicals, about 1,000 are used in everyday consumer products and are in need of safety reevaluation. The EPA placed 90 chemicals known to pose health risks on a list called the TSCA Work Plan and intends to place those chemicals high on its prioritization list.Included in the EPAโs new rules, the agency has set specific agendas for certain chemicals, particularly for paint and coating removal uses of two solvents, methylene chloride and n-methylpyrrolide, dry cleaning and aerosol degreasing uses of other solvents including trichloroethylene, and the vapor degreasing uses of trichloethylene.In December, the EPA announced ten chemicals it was making a priority to review, including asbestos and dioxane.When a chemical is deemed to pose an unreasonable risk the EPA must take action within two years, with the possibility of an extension to four years. Bans and phaseouts have to occur within five years of an assessment that a chemical is unreasonably dangerous.For new chemicals, the EPA must review and declare that a chemical is safe before it is allowed on the marketplace and can ban, require additional testing, or place limitations on new chemicals and their uses.Much of the funding will come from chemical manufacturer user fees. When a manufacturer wants their chemical tested, they must pay 50% of the cost if itโs already on the EPAโs agenda, or 100% if the EPA has not yet scheduled a review. They will pay fees for submitting test data, for notices of new chemicals, and other activities. Written by: Russell MaasManaging Editor & Senior Legal JournalistRussell Maas is a paralegal and the Managing Editor of AboutLawsuits.com, where he has reported on mass tort litigation, medical recalls, and consumer safety issues since 2010. He brings legal experience from one of the nationโs leading personal injury law firms and oversees the siteโs editorial strategy, including SEO and content development. Tags: Asbestos, Chemicals, Congress, Dioxane, EPAMore Lawsuit Stories Lawsuit Claims Abbott Sales Reps Practiced Medicine Without a License While Adjusting Spinal Cord Stimulator November 20, 2026 Roblox Lawsuit Claims Predator Groomed 11-Year-Old Boy, Causing PTSD, Depression and Anxiety November 20, 2026 Shiatsu Neck Massager Lawsuit Claims Device Caused Severe Burn Injuries November 20, 2026 0 Comments EmailThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Lawsuit Claims Abbott Sales Reps Practiced Medicine Without a License While Adjusting Spinal Cord Stimulator (Posted: 2 days ago)An Abbott SCS lawsuit claims the company’s sales representatives performed unlicensed medical procedures, potentially delaying removal of a failed implant.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITConsolidated Lawsuit Over Boston Scientific Spinal Cord Stimulator Problems Filed in MDL (11/09/2026)Abbott Sales Reps Kept Trying to Reprogram Failed SCS Implant: Lawsuit (11/02/2026)Abbott Proclaim Elite Lawsuit Alleges Spinal Cord Stimulator Malfunction Worsened Chronic Pain (10/29/2026) Parkinsonโs Disease Lawsuit Claims Dow and Corteva Sold Dangerous Chlorpyrifos Despite Safer Alternatives (Posted: 3 days ago)A California man’s chlorpyrifos lawsuit blames years of exposure to the pesticide for the development of Parkinson’s disease that forced him out of his profession.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITPesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (11/13/2026)Chlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinsonโs Disease (10/01/2026) Gabapentin Lawsuit Alleges Nerve Pain Drug Caused Severe Headaches, Memory Loss (Posted: 4 days ago)A Washington womanโs lawsuit claims she suffered persistent neurological problems after using gabapentin for fibromyalgia.MORE ABOUT: GABAPENTIN DEMENTIA LAWSUITNeurontin Dementia Lawsuit Alleges Gabapentin Caused Early-Onset Memory Loss (11/10/2026)Gabapentin Dementia Risks May Result in Lawsuits Against Drug Maker (09/17/2026)
Lawsuit Claims Abbott Sales Reps Practiced Medicine Without a License While Adjusting Spinal Cord Stimulator November 20, 2026
Roblox Lawsuit Claims Predator Groomed 11-Year-Old Boy, Causing PTSD, Depression and Anxiety November 20, 2026
Lawsuit Claims Abbott Sales Reps Practiced Medicine Without a License While Adjusting Spinal Cord Stimulator (Posted: 2 days ago)An Abbott SCS lawsuit claims the company’s sales representatives performed unlicensed medical procedures, potentially delaying removal of a failed implant.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITConsolidated Lawsuit Over Boston Scientific Spinal Cord Stimulator Problems Filed in MDL (11/09/2026)Abbott Sales Reps Kept Trying to Reprogram Failed SCS Implant: Lawsuit (11/02/2026)Abbott Proclaim Elite Lawsuit Alleges Spinal Cord Stimulator Malfunction Worsened Chronic Pain (10/29/2026)
Parkinsonโs Disease Lawsuit Claims Dow and Corteva Sold Dangerous Chlorpyrifos Despite Safer Alternatives (Posted: 3 days ago)A California man’s chlorpyrifos lawsuit blames years of exposure to the pesticide for the development of Parkinson’s disease that forced him out of his profession.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITPesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (11/13/2026)Chlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinsonโs Disease (10/01/2026)
Gabapentin Lawsuit Alleges Nerve Pain Drug Caused Severe Headaches, Memory Loss (Posted: 4 days ago)A Washington womanโs lawsuit claims she suffered persistent neurological problems after using gabapentin for fibromyalgia.MORE ABOUT: GABAPENTIN DEMENTIA LAWSUITNeurontin Dementia Lawsuit Alleges Gabapentin Caused Early-Onset Memory Loss (11/10/2026)Gabapentin Dementia Risks May Result in Lawsuits Against Drug Maker (09/17/2026)